# G207 Followed by Radiation Therapy in Malignant Glioma

> **NCT00157703** · PHASE1 · COMPLETED · sponsor: **MediGene** · enrollment: 9 (actual)

## Conditions studied

- Malignant Glioma

## Interventions

- **DRUG:** G207

## Key facts

- **NCT ID:** NCT00157703
- **Lead sponsor:** MediGene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2008-10
- **Final completion:** 2008-12
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2008-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00157703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00157703, "G207 Followed by Radiation Therapy in Malignant Glioma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00157703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*